Prizvalve valve replacement for failing bioprosthetic heart valves
This trial tests a new replacement valve (Prizvalve) for people whose bioprosthetic heart valve is worn out (narrowed or leaky). It is designed for those who are at high risk for another open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your current biological heart valve is either moderately or severely narrowed or leaking.
- You have symptoms like shortness of breath or chest pain that affect daily activities (NYHA class II or higher).
- Your heart team decides that you are at high risk for open-heart surgery or cannot have it safely.
- You understand the trial and agree to participate and follow up.
- You do not have severe valve issues like a clot, infection, or certain anatomical problems that would make the new valve unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests Prizvalve, a catheter-based procedure to replace a severely damaged “atrioventricular” valve in people at high risk from open-heart surgery. It may help reduce symptoms caused by valve narrowing or leaking when traditional surgery is not a good option.
This trial studies Prizvalve Pro™, a new transcatheter (catheter-based) aortic valve replacement, for people with severe aortic valve narrowing who are too high-risk for standard surgery. It may help your heart work better and improve symptoms by replacing the failing valve without open-heart surgery.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
This study tests a biological (tissue) heart valve replacement system designed to be easier to change later. It may help people who need valve surgery because their valve is narrowed or damaged.
This early-stage trial tests a new device called the ReValve System that replaces a damaged mitral valve (the valve that controls blood flow in your heart). The study is for people with a weakened heart who have leaking mitral valves and are experiencing heart failure symptoms.
This trial tests whether a new minimally invasive valve replacement device (put through a catheter) can improve health in people with severe right-sided tricuspid valve leaking. It’s for patients who are considered too high-risk for standard open-heart tricuspid surgery.
Hear when a new Failing Bioprosthetic Valves trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.